Related Experiment Video
Updated: Nov 29, 2025

10:54
Optimization of Radiochemical Reactions using Droplet Arrays
Published on: February 12, 2021
3.7K
Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis
Tao Guo1, Anton E P Adang, Guizhen Dong
1Pharmacopeia, Inc, PO Box 5350, Princeton, NJ 08543-5350, USA. tguo@pharmacop.com
Bioorganic & Medicinal Chemistry Letters
|March 18, 2004
Summary
Researchers discovered potent small molecule biaryl diketopiperazine FSH receptor agonists. These compounds were synthesized and evaluated using novel optimization libraries and parallel synthesis methods.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Endocrinology
Background:
- The follicle-stimulating hormone (FSH) receptor plays a crucial role in reproductive health.
- Developing small molecule agonists for the FSH receptor presents therapeutic opportunities.
Purpose of the Study:
- To design, synthesize, and evaluate novel biaryl diketopiperazine compounds as FSH receptor agonists.
- To identify potent and selective agonists for potential therapeutic applications.
Main Methods:
- Preparation of three biaryl diketopiperazine optimization libraries using solid-phase parallel synthesis.
- Employing a cyclization-release method for efficient compound library generation.
- Evaluation of over 300 synthesized compounds for FSH receptor agonist activity.
Main Results:
- Discovery of potent small molecule biaryl diketopiperazine FSH receptor agonists.
- Identification of compounds 10c (EC(50)=13 nM) and 11f (EC(50)=1.2 nM) with high potency.
- Successful synthesis and evaluation of a large library of diverse compounds.
Conclusions:
- Biaryl diketopiperazines represent a promising scaffold for developing FSH receptor agonists.
- The developed synthetic methodology enables efficient exploration of chemical space for drug discovery.
- Potent agonists were identified, warranting further investigation for therapeutic potential.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Structure-Activity Relationships and Drug Design
1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.6K

